AbbVie Inc. (ABBV)

Total Asset Turnover
since 2012

Difficulty: Beginner

AbbVie Inc., total asset turnover, long-term trends, calculation

	Total Asset Turnover	=	Net revenues¹	÷	Total assets¹
Dec 31, 2012	0.68	=	18,380	÷	27,008
Dec 31, 2013	0.64	=	18,790	÷	29,198
Dec 31, 2014	0.72	=	19,960	÷	27,547
Dec 31, 2015	0.43	=	22,859	÷	53,050
Dec 31, 2016	0.39	=	25,638	÷	66,099
Dec 31, 2017	0.40	=	28,216	÷	70,786

¹ USD $ in millions

Source: Based on data from AbbVie Inc. Annual Reports

AbbVie Inc., total asset turnover, long-term trends, comparison to competitors

	AbbVie Inc.	Abbott Laboratories	Allergan PLC	Amgen Inc.	Biogen Inc.	Bristol-Myers Squibb Co.	Celgene Corp.	Eli Lilly & Co.	Gilead Sciences Inc.	Johnson & Johnson	Merck & Co. Inc.	Pfizer Inc.	Regeneron Pharmaceuticals Inc.
Dec 31, 2012	0.68	0.59	0.42	0.31	0.54	0.49	0.46	0.66	0.44	0.55	0.45	0.32	0.66
Dec 31, 2013	0.64	0.51	0.38	0.28	0.58	0.42	0.48	0.66	0.48	0.54	0.42	0.30	0.71
Dec 31, 2014	0.72	0.49	0.25	0.28	0.68	0.47	0.44	0.53	0.71	0.57	0.43	0.29	0.73
Dec 31, 2015	0.43	0.49	0.11	0.29	0.55	0.52	0.34	0.56	0.62	0.53	0.39	0.29	0.73
Dec 31, 2016	0.39	0.40	0.11	0.28	0.50	0.58	0.40	0.55	0.53	0.51	0.42	0.31	0.70
Dec 31, 2017	0.40	0.36	0.13	0.27	0.52	0.62	0.43	0.51	0.37	0.49	0.46	0.31	0.67

Source: Based on data from AbbVie Inc. Annual Reports

AbbVie Inc., total asset turnover, long-term trends, comparison to Pharmaceuticals & Biotechnology sector

	AbbVie Inc.	Pharmaceuticals & Biotechnology
Dec 31, 2012	0.68	0.46
Dec 31, 2013	0.64	0.43
Dec 31, 2014	0.72	0.44
Dec 31, 2015	0.43	0.38
Dec 31, 2016	0.39	0.38
Dec 31, 2017	0.40	0.37

Source: Based on data from AbbVie Inc. Annual Reports

AbbVie Inc., total asset turnover, long-term trends, comparison to Health Care industry

Source: Based on data from AbbVie Inc. Annual Reports